Xtx Topco LTD Aim Immuno Tech Inc. Transaction History
Xtx Topco LTD
- $1.12 Billion
- Q2 2024
A detailed history of Xtx Topco LTD transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 14,526 shares of AIM stock, worth $3,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,526
Previous 14,115
2.91%
Holding current value
$3,631
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AIM
# of Institutions
39Shares Held
8.44MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.08MShares$1.02 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$497,1760.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$174,5660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA401KShares$100,2560.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny229KShares$57,2020.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $12M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...